Impact of Reimbursement for Biomarker Testing on Clinical PracticeVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. Geoffrey Oxnard and Lauren Ritterhouse deliberate on ways reimbursement issues are impacting clinical practice, particularly CMS’s “14-Day Rule.”
Dr. Steve O’Day understands that cost is a major concern for patients and urges oncologists to discuss the “big picture” with their patients so that they understand the full value of a treatment.
Dr. Alex Adjei shares an example of how precision medicine has drastically improved the quality of life for many cancer patients, but stresses the need to find more and better approaches to treating various cancer types.